Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

IMpower010: chemotherapy cleared postoperative ctDNA in 62% of patients who had it, and clearance tracked with longer DFS

The ESMO 2024 IMpower010 ctDNA update reported that chemotherapy converted 62% of patients who were ctDNA-positive after surgery to ctDNA-negative, and that this clearance was associated with longer disease-free survival.

Annals of Oncology